Real-world treatment patterns and characteristics among patients with agitation and dementia in the United States: findings from a large, observational, retrospective chart review
Manuscript Number:
20-0127R2
Author(s):
Ross A. Baker, Martin Cloutier, Ruth A. Duffy, Howard Fillit, Marjolaine Gauthier-Loiselle, Michael Grundman, Annie Guerin, Keva Gwin, Ann Hartry, Martin Ladouceur, Myrlene Sanon Aigbogun
Disclosures
Ross A. Baker
Sponsors:
Full time employee of Otsuka
Martin Cloutier
Consulting Fees:
I am an empoyee of Analysis Group, Inc., which has received consultancy fees from Otsuka Pharmaceutical Development & Commercialization, Inc.for the conduct of this study.
Ruth A. Duffy
Sponsors:
Full time employee of Otsuka Pharmaceutical Development and Commercialization
Howard Fillit
Consulting Fees:
Current consulting for which i receive fees ; Alector, vTv, Lundbeck/Otsuka, Biogen (RTI), Samus
Marjolaine Gauthier-Loiselle
Consulting Fees:
I am an empoyee of Analysis Group, Inc., which has received consultancy fees from Otsuka Pharmaceutical Development & Commercialization, Inc.for the conduct of this study.
Michael Grundman
Consulting Fees:
MG served as a paid clinical consultant to Otsuka
Annie Guerin
Consulting Fees:
I am an empoyee of Analysis Group, Inc., which has received consultancy fees from Otsuka Pharmaceutical Development & Commercialization, Inc.for the conduct of this study.
Keva Gwin
Sponsors:
Previously employed by Lundbeck
Ann Hartry
Sponsors:
Full time employee of Lundbeck, LLC
Martin Ladouceur
Consulting Fees:
At the time the study was conducted, I was an employee of Analysis Group, which has received consulting fees for this study.